Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas. (Q54459761)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

0 references

World Health Organization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jörg-Christian Tonn

7

object named as

Jörg C Tonn

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

author name string

Niklas Thon

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

Sabina Eigenbrod

2

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

Eva M Grasbon-Frodl

3

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

Michael Ruiter

4

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

Jan H Mehrkens

5

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

Simone Kreth

6

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

Hans A Kretzschmar

8

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

Friedrich W Kreth

9

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

Journal of Neuropathology & Experimental Neurology

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

68

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

11

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

1219-1228

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Amplified RNA synthesized from limited quantities of heterogeneous cDNA.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Comprehensive human genome amplification using multiple displacement amplification

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Evidence for a pathogenic role of different mutations at codon 188 of PRNP

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Molecular pathogenesis of oligodendroglial tumors

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Intratumoral distribution of 1p loss in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Clonal expansion of p53 mutant cells is associated with brain tumour progression

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181BEE1F1

21 January 2018

Identifiers

10.1097/NEN.0B013E3181BEE1F1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/19816195

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54459761&oldid=2042712701"